The field of immunotherapy is a work in progress and researchers are now expanding the use of this treatment and doing a better job of identifying the patients that will benefit the most from it.

The opinions expressed herein are the guest's alone and have not been reviewed by a WebMD physician. If you have questions about your health, you should consult your personal physician. This event is ...

I am a radiation oncologist and was recently referred a 71-year-old woman, diagnosed in October 2003 with a multifocal invasive ductal carcinoma (1.9 and 0.9 cm) -- grade 2, estrogen-receptor ...

This transcript has been edited for clarity. Harold J. Burstein, MD, PhD: I'm Dr. Harold Burstein, and this is Care Cues, a conversation about communication in patients with cancer. Today I'm going to ...

Harold Burstein, MD, PhD, from Dana-Farber Cancer Institute, reports on practice-changing data in metastatic breast cancer presented at the 2019 annual San Antonio Breast Cancer Symposium. Arguably ...